David A. Siegel Cv Rx, Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Cv Rx, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 81,000 shares of CVRX stock, worth $528,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,000Holding current value
$528,120% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding CVRX
# of Institutions
99Shares Held
16.3MCall Options Held
53.4KPut Options Held
32.3K-
Johnson & Johnson New Brunswick, NJ4.1MShares$26.8 Million16.67% of portfolio
-
Nea Management Company, LLC Timonium, MD2.03MShares$13.2 Million2.35% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT1.23MShares$8.02 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$6.56 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$5.71 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $134M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...